Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Pfizer Inc.
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Number of employees : 88 300 people.
Sales per Business
2019
USD (in Million)%
Biopharma39,41976.2%
Upjohn10,23319.8%
Other Business Activities2,0984.1%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States25,32947.2%23,85246.1% -5.83%
Developed Europe9,11617%8,70116.8% -4.55%
Emerging Markets8,35915.6%8,07615.6% -3.39%
China4,2928%4,6589% +8.52%
Japan4,2928%4,1408% -3.54%
Developed Rest of World2,2594.2%2,3254.5% +2.91%
Managers and Directors
NameAgeSinceTitle
Albert Bourla582020Chairman, Chief Executive & Operating Officer
Frank D'Amelio622010Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca51-Executive VP, Chief Digital & Technology Officer
Suzanne Nora Johnson632007Independent Director
Helen H. Hobbs, Dr.672011Independent Director
Shantanu Narayen56-Lead Independent Director
James Smith602014Independent Director
Joseph Echevarria632015Independent Director
Ronald E. Blaylock602017Independent Director
Dan R. Littman, Dr.672018Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,399,962,916 5,557,351,385 59.1% 3,840,000,000 40.9% 59.1%
Shareholders
NameEquities%
The Vanguard Group, Inc. 426,111,205 7.67%
SSgA Funds Management, Inc. 289,091,326 5.20%
Capital Research & Management Co. (World Investors) 259,186,297 4.66%
Wellington Management Co. LLP 234,743,957 4.22%
Capital Research & Management Co. 142,320,700 2.56%
BlackRock Fund Advisors 134,389,509 2.42%
Geode Capital Management LLC 89,213,456 1.61%
Northern Trust Investments, Inc.(Investment Management) 68,628,339 1.23%
Norges Bank Investment Management 59,372,776 1.07%
State Farm Investment Management Corp. 56,536,168 1.02%
Holdings
NameEquities%Valuation
Pfizer Limited (500680) 29,243,04263.9%2,044,201,514 USD
SpringWorks Therapeutics, Inc. (SWTX) 4,593,8479.42%333,145,784 USD
Morphic Holding, Inc. (MORF) 2,528,8358.12%84,842,414 USD
Cortexyme, Inc. (CRTX) 2,879,9739.76%80,005,650 USD
BioAtla, Inc. (BCAB) 2,238,0906.96%76,117,441 USD
Sosei Group Corporation (4565) 1,885,1362.34%32,865,951 USD
NextCure, Inc. (NXTC) 1,970,7597.15%21,481,273 USD
ESSA Pharma Inc. (EPI) 1,675,0004.99%19,982,750 USD
Wave Life Sciences Ltd. (WVE) 1,875,0003.84%14,756,250 USD
RaQualia Pharma Inc. (4579) 743,0003.55%7,196,475 USD
Company contact information
Pfizer Inc.
235 East 42nd Street
New York, NY 10017-5755

Phone : +1.212.733.2323
Web : http://www.pfizer.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Pfizer Inc.
Sector Pharmaceuticals - NEC